INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 116 filers reported holding INHIBRX INC in Q4 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,639,445 | -47.4% | 743,294 | -25.5% | 0.86% | -49.3% |
| Q2 2023 | $25,915,427 | +10.4% | 998,283 | -19.8% | 1.70% | +13.0% |
| Q1 2023 | $23,483,489 | -14.2% | 1,244,488 | +12.1% | 1.50% | -7.5% |
| Q4 2022 | $27,354,909 | +90.4% | 1,110,183 | +38.7% | 1.62% | +94.1% |
| Q3 2022 | $14,364,000 | +755.5% | 800,177 | +440.9% | 0.84% | +497.1% |
| Q2 2022 | $1,679,000 | -85.4% | 147,935 | -71.3% | 0.14% | -83.9% |
| Q1 2022 | $11,466,000 | -28.8% | 514,640 | +39.6% | 0.87% | -7.4% |
| Q4 2021 | $16,100,000 | – | 368,679 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |